Steven Cohen’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-40,563
Closed -$1.74M – 4593
2026
Q2
$1.74M Sell
40,563
-1,170,162
-97% -$43.6M ﹤0.01% 2478
2026
Q1
$48.7M Sell
1,210,725
-527,660
-30% -$22.7M 0.06% 381
2025
Q4
$88M Buy
1,738,385
+466,358
+37% +$16.6M 0.1% 214
2025
Q3
$37M Buy
+1,272,027
New +$29.4M 0.06% 336
2025
Q1
– Sell
-194,027
Closed -$8.21M – 2568
2024
Q4
$8.21M Buy
194,027
+22,454
+13% +$994K 0.02% 754
2024
Q3
$7.58M Buy
171,573
+52,573
+44% +$2M 0.02% 751
2024
Q2
$4.31M Sell
119,000
-1,056,148
-90% -$41.9M 0.01% 881
2024
Q1
$50.7M Buy
1,175,148
+190,824
+19% +$6.8M 0.12% 197
2023
Q4
$15.1M Buy
+984,324
New +$12.5M 0.04% 542
2023
Q2
– Sell
-1,037,128
Closed -$8.05M – 2815
2023
Q1
$8.05M Buy
+1,037,128
New +$8.01M 0.02% 622
2022
Q4
– Sell
-121,000
Closed -$2.58M – 1807
2022
Q3
$2.58M Buy
+121,000
New +$2.27M 0.01% 875

Other funds holding VERA

Steven Cohen's VERA Position: Q3 2026 in Review

Steven Cohen sold out of Vera Therapeutics (VERA) in Q3 2026, closing a stake of 40,563 shares — an estimated $1.74M sold.

Steven Cohen first reported a position in VERA in Q3 2022 and held it in 11 quarters. The position peaked at $88M in Q4 2025. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Steven Cohen reported no remaining Vera Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 40,563 Vera Therapeutics shares in Q3 2026, an estimated $1.74M.
  • Steven Cohen first reported a position in Vera Therapeutics in Q3 2022 and held it in 11 quarters.
  • Steven Cohen's Vera Therapeutics position peaked at $88M in Q4 2025.
  • 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.